About the Company
the mission of infinity pharmaceuticals, inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of difficult-to-treat diseases, with a strong focus in oncology and inflammation. small molecule discovery and development capabilities infinity’s programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation. strategic alliances building on its strengths in innovative small molecule drug discovery and development, infinity has established significant alliances with leading pharmaceutical and biotechnology companies to help realize the full potential of its product pipeline. business and scientific expertise the company has assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $INFI News
Infinity Pharmaceuticals Inc INFIQ
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Biotech bankruptcies hit a record despite sector’s recovery
Failure to obtain shareholder approval for its proposed merger agreement with MEI Pharma (MEIP) sent Infinity Pharmaceuticals (OTC:INFIQ) underwater in September. Other notable biotech bankruptcies in ...
Infinity Pharmaceuticals Announces Value Preservation and Maximization Plan
Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a potential first ...
Pricing Drives User To Upstart Storage Vendor
Jarrett Goetz, senior manager of IT infrastructure at Infinity Pharmaceuticals Inc., a biotech company founded in 2001 with $85 million in funding,, had the big vendors in, and has had previous ...
David Schnell's Net Worth
Trubion Pharmaceuticals, Inc, INFINITY PHARMACEUTICALS, INC., SENOMYX INC, and BAXANO SURGICAL, INC.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with ...
Infinity (INFIQ) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
OnKure Announces the Appointment of Samuel Agresta, M.D., as Chief Medical Officer
Dr. Agresta also served as a Director and Chief Medical Officer at Infinity Pharmaceuticals, Inc. where he was responsible for the Phase 1 and 2 developments of the PI3Ky inhibitor, IPI-549.
Madrigal Pharmaceuticals Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Infinity Pharmaceuticals, Inc. (INFIQ)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Infinity Pharmaceuticals, Inc. (INFIQ)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...